North America Synthetic Biology Market Forecast to 2028

North America Synthetic Biology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Products (Enzymes, Chassis Organisms, Oligonucleotides, and Xeno-Nucleic Acids), Technology (Measurement & Modeling, Cloning & Sequencing, Genome Engineering, Gene Synthesis, Nanotechnology, and Others), and Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications, and Others)

Report Code : BMIRE00025392 | Region : North America | Industry : Biotechnology | Published Date : 15/Jul/2022

The North America synthetic biology market is expected to grow from US$ 4,313.62 million in 2021 to US$ 15,223.61 million by 2028; it is estimated to grow at a CAGR of 19.7% from 2021 to 2028.

Synthetic biology is an emerging concept that has numerous applications in the chemicals, agriculture, pharmaceuticals, and energy industries. Various start-ups offer gene synthesis products/services for biological processes. For example, Benchling provides CAD tools, GenScript offers gene synthesis, Ginkgo Bioworks assists in organism engineering, Transcriptis (a bioinformatics company) offers solutions facilitating cloud labs/automation, and Glowee offers consumer products. Amid the adverse effects of the COVID-19 pandemic on start-up performance, the bioeconomy accelerated in the first half of 2020. 56 synthetic biology businesses raised more than US$ 3 billion in equity financing in the first half of 2020, compared to 65 companies raising US$ 1.9 billion during the same period in 2020. The new generation of biopharma businesses uses synthetic biology to improve cell treatment and gene therapy and support early cancer detection. With such rising investments by companies, the demand for synthetic biology-based new techniques is increasing, thereby driving the synthetic biology market growth across the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America synthetic biology market . The North America synthetic biology market is expected to grow at a notable CAGR during the forecast period.

North America Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

North America Synthetic Biology Market Segmentation

The North America synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to be fastest growing during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to grow at the fastest rate during the forecast period. The North America synthetic biology market is segmented into the US, Canada, and Mexico.

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the North America synthetic biology market.

Oligonucleotides Segment to Dominate North America Synthetic Biology Market During 2021-2028

According to a new market research study on “North America Synthetic Biology Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Products, Technology, and Application ” is expected to reach US$ 15,223.61 million by 2028 from US$ 4,313.62 million in 2021. The market is estimated to grow at a CAGR of 19.7% from 2021 to 2028. The report provides trends prevailing in the North America synthetic biology market along with the drivers and restraints pertaining to the market growth. Growing investments in synthetic biology is the major factor driving the growth of the North America synthetic biology market . However, renewed regulations for biotechnology may hamper the growth of the market hinders the growth of North America synthetic biology market .

The North America synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020 and genome engineering is expected to be fastest growing during forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to be fastest growing during forecast period. Based on country, the North America synthetic biology market is segmented into the US, Canada, and Mexico

Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the North America synthetic biology market . The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System. The acquisition of the MAST platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Synthetic Biology Market – By Product

1.3.2 North America Synthetic Biology Market – By Technology

1.3.3 North America Synthetic Biology Market – By Application

1.3.4 North America Synthetic Biology Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Synthetic Biology Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Synthetic Biology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Investments in Synthetic Biology

5.1.2 Accentuating Number of Start-Ups

5.2 Key Market Restraints

5.2.1 Renewed Regulations for Biotechnology

5.3 Key Market Opportunities

5.3.1 Collaboration Between Companies

5.4 Future Trends

5.4.1 Advanced Synthetic Biology

5.5 Impact Analysis

6. Synthetic Biology Market– North America Analysis

6.1 North America Synthetic Biology Market Revenue Forecast and Analysis

7. North America Synthetic Biology Market Analysis – By Product

7.1 Overview

7.2 North America Synthetic Biology Market, By Product, 2021 & 2028 (%)

7.3 Enzymes

7.3.1 Overview

7.3.2 Enzyme: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Oligonucleotides

7.4.1 Overview

7.4.2 Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Chassis Organisms

7.5.1 Overview

7.5.2 Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Xeno-Nucleic Acids

7.6.1 Overview

7.6.2 Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

8. North America Synthetic Biology Market Analysis – By Technology

8.1 Overview

8.2 North America Synthetic Biology Market Share by Technology - 2021 & 2028 (%)

8.3 Gene Synthesis

8.3.1 Overview

8.3.2 Gene Synthesis: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.4 Genome Engineering

8.4.1 Overview

8.4.2 Genome Engineering: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.5 Measurement and Modeling

8.5.1 Overview

8.5.2 Measurement and Modeling: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.6 Cloning and Sequencing

8.6.1 Overview

8.6.2 Cloning and Sequencing: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.7 Nanotechnology

8.7.1 Overview

8.7.2 Nanotechnology: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9. North America Synthetic Biology Market Analysis – By Application

9.1 Overview

9.2 North America Synthetic Biology Market Share by Application - 2021 & 2028 (%)

9.3 Medical Applications

9.3.1 Overview

9.3.2 Medical Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.1 Drug Discovery and Therapeutics

9.3.2.1.1 Overview

9.3.2.1.2 Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.3.2.2 Pharmaceuticals

9.3.2.2.1 Overview

9.3.2.2.2 Pharmaceuticals: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.4 Industrial Applications

9.4.1 Overview

9.4.2 Industrial Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.5 Food & Agriculture

9.5.1 Overview

9.5.2 Food & Agriculture: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.6 Environmental Applications

9.6.1 Overview

9.6.2 Environmental Applications: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Synthetic Biology Market Revenue and Forecast to 2028 (US$ Million)

10. North America Synthetic Biology Market – Country Analysis

10.1 North America: Synthetic Biology Market

10.1.1 Overview

10.1.2 North America Synthetic Biology Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1 US: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Overview

10.1.2.1.2 US: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.1.3 US: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.1.4 US: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.1.5 US: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.6 US: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.2 Canada: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Overview

10.1.2.2.2 Canada: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.2.3 Canada: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.2.4 Canada: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.2.5 Canada: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.6 Canada: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

10.1.2.3 Mexico: Synthetic Biology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Overview

10.1.2.3.2 Mexico Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.3.3 Mexico: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

10.1.2.3.4 Mexico: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

10.1.2.3.5 Mexico: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.6 Mexico: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Agilent Technologies, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MERCK KGaA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 New England Biolabs

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Integrated DNA Technologies

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Twist Bioscience

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 GenScript Biotech Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Novozymes A/S

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Codexis

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Amyris Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Synthetic Biology Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2. US: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 3. US: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 4. US: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 5. US: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 6. Canada: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 7. Canada: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 8. Canada: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 9. Canada: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 10.   Mexico: Synthetic Biology Market, by Product, 2019–2028 (USD Million)

Table 11.   Mexico: Synthetic Biology Market, by Technology, 2019–2028 (USD Million)

Table 12.   Mexico: Synthetic Biology Market, by Application, 2019–2028 (USD Million)

Table 13.   Mexico: Synthetic Biology Market, by Medical Application, 2019–2028 (USD Million)

Table 14.   Organic Developments

Table 15.   Inorganic Developments

Table 16.   Glossary of Terms

LIST OF FIGURES.

Figure 1. North America Synthetic Biology Market Segmentation

Figure 2. North America Synthetic Biology Market, By Country

Figure 3. North America Synthetic Biology Market Overview

Figure 4. North America Synthetic Biology Market, By Product

Figure 5. North America Synthetic Biology Market, By Country

Figure 6. North America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. North America Synthetic Biology Market: Impact Analysis of Drivers and Restraints

Figure 9. North America Synthetic Biology Market– Revenue Forecast and Analysis

Figure 10.   North America Synthetic Biology Market, by Product, 2021 & 2028 (%)

Figure 11.   North America Enzymes: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.   North America Oligonucleotide: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.   North America Chassis Organisms: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.   North America Xeno-Nucleic Acids: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.   North America Synthetic Biology Market Share by Technology - 2021 & 2028 (%)

Figure 16.   North America Gene Synthesis: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.   North America Genome Engineering: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.   North America Measurement and Monitoring: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.   North America Cloning and Sequencing: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.   North America Nanotechnology: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.   North America Others: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.   North America Synthetic Biology Market Share by Application - 2021 & 2028 (%)

Figure 23.   North America Medical Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.   North America Drug Discovery and Therapeutics: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.   North America Pharmaceuticals: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.   North America Industrial Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.   North America Food & Agriculture: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.   North America Environmental Applications: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29.   North America Others: Synthetic Biology Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.   North America: Synthetic Biology Market Revenue Overview, by Key Country – Revenue (2021) (USD Million)

Figure 31.   North America Synthetic Biology Market Revenue and Forecasts to 2028, By Country (%)

Figure 32.   US: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.   Canada: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.   Mexico: Synthetic Biology Market Revenue and Forecasts to 2028 (US$ Million)

The List of Companies - North America Synthetic Biology Market

● Agilent Technologies, Inc.

● Amyris

● Codexis

● Genscript Biotech corporation

● Integrated DNA Technologies

● Merck KGaA

● New England Biolabs

● Novozymes A/S

● Thermo Fisher Scientific

● Twist Bioscience

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America synthetic biology market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America synthetic biology market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the synthetic biology market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP